| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Rouan Sarah Kathryn is a Director at Viking Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $142K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | VKTX Viking Therapeutics, Inc. | Director | Buy | 1,240 | $24.15 | $29,942.78 | New | +9.7% | +34.7% | |
| Oct 25, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 11,000 | $80.89 | $889,790.00 | -100% | -55.2% | -55.9% | |
| Feb 8, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 25,000 | $28.05 | $701,250.00 | -100% | +176.6% | +12.7% | |
| Jan 19, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 30,000 | $23.05 | $691,500.00 | -100% | +197.1% | +50.0% |